Gerardo Antonio Umanzor, MD of Liga Contra el Cáncer answers frequently asked questions on paclitaxel shown to be superior to IV paclitaxel: a Phase III clinical study in metastatic breast cancer.
Advertisement
Frequently Asked Questions on the Phase III Study of Oral Paclitaxel in Metastatic Breast Cancer #SABCS19
By Editor